NGNE
Neurogene Inc
NASDAQ: NGNE · HEALTHCARE · BIOTECHNOLOGY
$26.48
-3.53% today
Updated 2026-04-29
Market cap
$422.41M
P/E ratio
—
P/S ratio
438.73x
EPS (TTM)
$-4.24
Dividend yield
—
52W range
$12 – $37
Volume
0.2M
Neurogene Inc (NGNE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-31.40%
ROA
-20.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | — | $-10.51M | — | — | — |
| 2012 | — | $-7.71M | — | — | — |
| 2013 | — | $-8.73M | — | — | — |
| 2014 | — | $-23.82M | — | — | — |
| 2015 | — | $-21.86M | — | — | — |
| 2016 | — | $-37.00M | — | — | — |
| 2017 | — | $-50.18M | — | — | — |
| 2018 | $25.00M | $-31.59M | 100.00% | -94.10% | -126.34% |
| 2019 | — | $-69.44M | — | — | — |
| 2020 | — | $-33.28M | — | — | — |
| 2021 | $0.00 | $-50.52M | — | — | — |
| 2022 | $0.00 | $-55.19M | — | — | — |
| 2023 | $0.00 | $-36.32M | — | — | — |
| 2024 | $925000.00 | $-75.14M | -251.03% | -8,930.27% | -8,123.68% |
| 2025 | $0.00 | $-90.35M | — | — | — |